image

The best stocks to buy since 1993

Latest issue now available

Nexxen - Shares rocket to new high: Gain 57%

December 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • NEXN
  • Price:
  • 387p
The shares soared following a record Q3, and with the bulk of political election CTV spending typically occurring just 5–6 weeks before Election Day, Q4 is set to be another blowout quarter. In Q3, sales increased by 12% year-on-year to US$85.5m, while EBITDA surged 49% to US$31.6m, demonstrating strong operational leverage. The EBITDA margin expanded to 37% from 28%. Programmatic revenue reached US$81.6m, with growth observed across 10 of the 11 industry verticals. The strongest gains were in the government, finance, health and automotive sectors, while the travel vertical experienced a decline. Notably, CTV revenue saw a major year-on-year increase, generating US$29.7m sales (a blistering +52% growth), accounting for 36% of prog ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe